Dr. Nikolai A. Bildzukewicz is Assistant Professor of Clinical Surgery at the Keck School of Medicine of USC. He is also the Associate Program Director for the general surgery residency program as well as the minimally-invasive and bariatric surgery fellowship. Originally from Pennsylvania, he obtained his medical degree from Jefferson Medical College in Philadelphia. Upon graduation from medical school, Dr. Bildzukewicz was commissioned as a lieutenant in the United States Navy. He then completed his general surgery internship at the Naval Medical Center San Diego. Following his internship, he served several months as a General Medical Officer (GMO) at Naval Hospital Great Lakes, providing medical care to recruits going through “boot camp.” He then reported for training at the Naval Aerospace Medical Institute in Pensacola, FL, where he graduated as a Naval Flight Surgeon. He spent the next two years on active duty as a flight surgeon, providing medical care to military pilots, aircrew, and sailors both ashore and at sea. In 2005, he returned to Jefferson to complete his general surgery training. In 2012, he completed his fellowship training in minimally-invasive, bariatric, and robotic surgery at the University of California San Diego.
His clinical interests include the diagnosis and treatment of gastroesophageal reflux disease (GERD), hiatal and paraesophageal hernias, and esophageal motility disorders including achalasia. He also focuses on the advanced laparoscopic repair of both inguinal and ventral hernias, as well as advanced techniques for abdominal wall reconstruction. His research interests are in advancing minimally-invasive surgical techniques. These include single-incision, robotic, advanced endoscopic, and natural orifice surgery (or NOTES). In addition, he has a special interest in the surgical education of both residents and medical students.
Dr. Bildzukewicz was recently selected by his peers as an outstanding practicing doctor in Southern California. After an extensive nomination and research process, the results were published in Super Doctors Rising Stars, a special advertising section in the August 2014 issue of Los Angeles magazine.
Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc. 2017 May; 31(5):2096-2102. View in: PubMed
Gastric cancer in the young: An advanced disease with poor prognostic features. J Surg Oncol. 2017 Mar; 115(4):371-375. View in: PubMed
Post-Nissen Dysphagia and Bloating Syndrome: Outcomes After Conversion to Toupet Fundoplication. J Gastrointest Surg. 2017 Mar; 21(3):441-445. View in: PubMed
Gastric cancer in the young: An advanced disease with poor prognostic features. J Surg Oncol. 2016 Dec 23. View in: PubMed
Post-Nissen Dysphagia and Bloating Syndrome: Outcomes After Conversion to Toupet Fundoplication. J Gastrointest Surg. 2016 Nov 10. View in: PubMed
A Durable Laparoscopic Technique for the Repair of Large Paraesophageal Hernias. Am Surg. 2016 Oct; 82(10):911-915. View in: PubMed
Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc. 2016 Aug 23. View in: PubMed
Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc. 2016 Aug; 30(8):3289-96. View in: PubMed
Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD. Surg Endosc. 2016 Aug; 30(8):3225-30. View in: PubMed
Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 Patients. J Am Coll Surg. 2015 Jul; 221(1):123-8. View in: PubMed
Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U. S. Food and Drug Administration approval. Am Surg. 2014 Oct; 80(10):1034-8. View in: PubMed
Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer. Surg Endosc. 2014 Feb; 28(2):492-9. View in: PubMed
Targeting PARP-1 Allosteric Regulation Offers Therapeutic Potential against Cancer. Cancer Res. 2014 Jan 1; 74(1):31-7. View in: PubMed
Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer. Cancer Res. 2014 Jan 01; 74(1):31-7. View in: PubMed
Transgastric large-organ extraction: the initial human experience. Surg Endosc. 2013 Feb; 27(2):394-9. View in: PubMed
Appendicitis following virtual colonoscopy: a case report. J Gastrointest Surg. 2012 Dec; 16(12):2291-3. View in: PubMed
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. PLoS One. 2010 Nov 29; 5(11):e15455. View in: PubMed
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. PLoS One. 2010; 5(11):e15455. View in: PubMed
A pseudoaneurysm of the inferior epigastric artery after laparoscopic right hemicolectomy. Am Surg. 2009 Dec; 75(12):1266-8. View in: PubMed